Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register

Diab Vasc Dis Res. 2017 May;14(3):226-235. doi: 10.1177/1479164116683637. Epub 2017 Feb 1.

Abstract

Background: Previous studies have shown a U-shaped relationship between systolic blood pressure and risk of all-cause of mortality in patients with type 2 diabetes and renal impairment.

Aims: To evaluate the associations between time-updated systolic blood pressure and time-updated change in systolic blood pressure during the follow-up period and risk of all-cause mortality in patients with type 2 diabetes and renal impairment.

Patients and methods: A total of 27,732 patients with type 2 diabetes and renal impairment in the Swedish National Diabetes Register were followed for 4.7 years. Time-dependent Cox models were used to estimate risk of all-cause mortality. Time-updated mean systolic blood pressure is the average of the baseline and the reported post-baseline systolic blood pressures.

Results: A time-updated systolic blood pressure < 130 mmHg was associated with a higher risk of all-cause mortality in patients both with and without a history of chronic heart failure (hazard ratio: 1.25, 95% confidence interval: 1.13-1.40 and hazard ratio: 1.26, 1.17-1.36, respectively). A time-updated decrease in systolic blood pressure > 10 mmHg between the last two observations was associated with higher risk of all-cause mortality (-10 to -25 mmHg; hazard ratio: 1.24, 95% confidence interval: 1.17-1.32).

Conclusion: Both low systolic blood pressure and a decrease in systolic blood pressure during the follow-up are associated with a higher risk of all-cause mortality in patients with type 2 diabetes and renal impairment.

Keywords: Type 2 diabetes; all-cause mortality; blood pressure; cardiovascular outcomes; renal impairment.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure* / drug effects
  • Cause of Death
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / mortality*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Diabetic Nephropathies / diagnosis
  • Diabetic Nephropathies / mortality*
  • Diabetic Nephropathies / physiopathology
  • Female
  • Glomerular Filtration Rate
  • Heart Failure / mortality
  • Heart Failure / physiopathology
  • Humans
  • Hypertension / diagnosis
  • Hypertension / drug therapy
  • Hypertension / mortality*
  • Hypertension / physiopathology
  • Kidney / physiopathology*
  • Longitudinal Studies
  • Male
  • Prognosis
  • Proportional Hazards Models
  • Registries
  • Risk Assessment
  • Risk Factors
  • Sweden / epidemiology
  • Systole
  • Time Factors

Substances

  • Antihypertensive Agents